Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
about
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cellsThe lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cellsFibromodulin suppresses nuclear factor-kappaB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosisMolecular alterations underlying the enhanced disruption of spermatogenesis by 2,5-hexanedione and carbendazim co-exposureInhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.Downregulation of Lysyl Oxidase Protects Retinal Endothelial Cells From High Glucose-Induced ApoptosisLysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasionDiverse biological functions of extracellular collagen processing enzymesGenetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer.The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cellsApoptosis regulates notochord development in Xenopus.RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1.A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.Oxidative stress as a mediator of cardiovascular disease.Lysyl oxidase: a potential target for cancer therapy.Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis.Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype.Lysyl oxidase regulates MMTV promoter: indirect evidence of histone H1 involvement.Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells.Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells.Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts.Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients.The IRF family of transcription factors: Inception, impact and implications in oncogenesis.Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation.Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells.Collagen advanced glycation inhibits its Discoidin Domain Receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts.Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population.Oncoprotein suppression of tumor necrosis factor-induced NF kappa B activation is independent of Raf-controlled pathways.Functional importance of lysyl oxidase family propeptide regions.Molecular characterization of lysyl oxidase-mediated extracellular matrix remodeling during mouse decidualization.
P2860
Q24301022-6886BB1A-17CF-4506-8C2A-4DB6D9495CA9Q24307235-2F3CAD3D-5948-4AD1-9B96-8B64169265A9Q28386926-75B3CF5C-93BB-4D12-AFE7-60B8EF6C8394Q28568892-D5A389A2-643E-4398-8613-FD3D98A6B5FAQ30009534-1C2EA117-CFFB-4EFB-B343-8CE681506620Q33727611-7CBFFDE7-1D61-4A4B-8EB4-8C3F54065ECBQ33748104-6480EEFE-68B6-41C7-B025-EE74CEA2D7DDQ33867402-B2368C14-FDDE-4E19-8A01-01A7023B693EQ34206164-27513100-D66F-47E6-8F09-32106DC265B4Q34764399-BDD82BD1-0842-45F0-835D-083293D62F54Q36165491-E60C986C-907E-4B5A-947F-16E60D2FD8E3Q36259191-F592FB58-5095-4E1A-8B2C-655796251E59Q36265638-3DF8D5D2-DB58-4722-BA87-78765991DD95Q37041619-D433FFBF-CFBB-4DCB-A8F3-0808FF1C8426Q37225793-FC9472A0-3004-4CE5-92E7-6629278EA5E5Q37247886-392E5A57-854D-443A-8CB7-F5C216F55884Q37312261-1A7A3C32-BCF1-47E4-9EB5-51746370AC6CQ37347497-2D170537-D3A2-4E87-9892-2EF4E7469243Q37515474-3CB0DD99-84D3-4C04-96BF-E3096272D32AQ37780644-97AFDC5D-4641-4524-A0D2-99C296CC2D00Q37812321-5A901AA4-BD66-477A-A8C5-4C036CC06BC3Q38082753-AAA219BD-686D-43EB-A4CB-2DC519B28622Q38723997-2067302D-4035-4363-9ECD-3B76A6256B13Q39224283-7BC2F11A-5C34-40C1-874B-DDF0ED8375B2Q39458122-51AF84FC-2E33-4127-BCDF-29BA07B114ABQ39825713-4F03ADEF-3097-4A69-9F44-B266C8BA9E1BQ40243976-BC734D6E-3184-4385-A7E1-0561A2077302Q40251892-60ABCFAB-C7FD-4E36-8EC0-1A53E58701EAQ40531209-726E978D-0C14-4576-A700-FEF1F47EC6BFQ40642135-C210B64E-2C33-40E2-A22C-C43B74681FE9Q41694382-38547D3F-748E-4BEC-8F18-EBCE1A838B14Q41888239-5CE95C66-A196-49AC-8010-07B51DAA5958Q42005506-C5F29E02-7A68-4642-8EBF-02036210C3F1Q42423477-7C699F9A-BCF4-49A0-BCEA-A5E19D0A8D6DQ42845545-73ADFE00-B75F-44BA-BE1A-1534C8EA4C80Q43469688-EAFD3A37-1DBC-45BC-AE79-04D6AF7170FBQ43990096-0AF8E36A-BD48-4CDC-88D8-BC62DF9E4B12Q47584936-7E47880F-C862-4F65-A1E6-AD894F3C1D6FQ47834323-BA6E194D-EA41-4592-9B75-33587BB3D91D
P2860
Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@ast
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@en
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@nl
type
label
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@ast
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@en
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@nl
prefLabel
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@ast
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@en
Lysyl oxidase inhibits ras-med ...... ting activation of NF-kappa B.
@nl
P2093
P2860
P1476
Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B
@en
P2093
Gail E Sonenshein
Herbert M Kagan
Stefania Pianetti
P2860
P304
P356
10.1128/MCB.23.7.2251-2263.2003
P407
P577
2003-04-01T00:00:00Z